Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Sarepta, Gilead

June 5, 2018 11:07 PM UTC

Neuromuscular disease company Sarepta Therapeutics Inc. (NASDAQ:SRPT) hired Louise Rodino-Klapac as VP of gene therapy at its newly created gene therapy unit. She will continue to serve as acting CSO at Myonexus Therapeutics Inc. (New Albany, Ohio).

Gilead Sciences Inc. (NASDAQ:GILD) said EVP of Strategy Martin Silverstein will step down at the end of August. He is succeeded by SVP of Corporate Development Andrew Dickinson as EVP of corporate development and strategy...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article